Oxurion: Its Subsidiary Axiodis CRO Forms a Partnership with KYomed Innov & Ceiso
Oxurion has announced that its subsidiary Axiodis CRO has entered into a strategic partnership with KYomed INNOV & CEISO, a French CRO specializing in digital health and medical devices. Axiodis CRO will provide specialized biometric services, including clinical data management, biostatistics, statistical programming, database design, and study documentation, in support of several clinical development projects led by KYomed INNOV & CEISO.
A Partnership Meeting the Growing Need for Biometric Expertise
Axiodis CRO offers KYomed INNOV & CEISO specialized biometric services, including clinical data management, biostatistics, statistical programming, database design, and study documentation. This model addresses a market-identified need: as clinical development becomes increasingly data-intensive, many full-service CROs prefer to outsource biometric expertise rather than maintain highly specialized teams internally.
A Replicable Model Across the European Market
Oxurion believes that this partnership exemplifies a scalable model that can be replicated across the European clinical research market. Axiodis CRO acts as an expert partner complementing the clinical and operational capabilities of full-service CROs, while the demand for flexible, high-value scientific expertise continues to grow.
Approximately 110,000 Euros in Revenue Expected in the First Year
Based on the current level of activity and identified development opportunities, this collaboration is expected to generate approximately 110,000 euros in annual revenue over the next twelve months, with potential exceeding 170,000 euros per year as the scope of services expands.
